Search for: "Bayer Pharmaceuticals" Results 1 - 20 of 925
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
2 Feb 2024, 7:11 am by Gregg Hollander
  If you believe you qualify to file a lawsuit against Bayer Pharmaceuticals due to damage caused by the Mirena IUD, contact a personal injury lawyer. [read post]
1 Feb 2024, 5:00 am by The Petrie-Flom Center Staff
A good starting point is cocaine, first introduced in the U.S. by the pharmaceutical company Parke, Davis in 1883. [read post]
15 Jan 2024, 3:16 am by Miquel Montañá (Clifford Chance)
However, the FMC had doubts as to whether this strict liability standard was in line with article 9(7) of Directive 2004/48/EC, as interpreted by the CJEU in its judgment of 12 September 2019 (case C-688/17 Bayer Pharma and Richter Gedeon). [read post]
4 Jan 2024, 8:03 pm by Hyman Phelps McNamara
  Deb assists pharmaceutical drug companies of all sizes on regulatory requirements and strategies related to obtaining FDA approval and other paths to market, as well as on post-marketing regulatory requirements. [read post]
13 Dec 2023, 1:29 am by Rose Hughes
The recent Board of Appeal decision in T 1356/21 covered a number of interesting legal points in the field of pharmaceutical patents. [read post]
29 Nov 2023, 5:00 am by Vincent Joralemon
Challengers soon arrived — Bayer’s Levitra and Eli Lilly’s Cialis broke onto the ED scene in the early 2000s. [read post]
24 Nov 2023, 12:19 am by Kluwer Patent blogger
‘Firstly, companies like Siemens, Bayer, Ericsson have patents to protect our innovations, our inventions, in which we put a lot of effort and R&D money. [read post]
20 Nov 2023, 3:32 pm by William D. Kickham, Esq.
This marks the fourth consecutive legal setback for Bayer, which is battling about165,000 personal injury claims linked to Roundup following its 2018 acquisition of Monsanto, and this verdict may intensify investor pressure on the German pharmaceutical and agricultural chemicals company to reassess its legal strategy. [read post]
24 Aug 2023, 9:41 am by Annsley Merelle Ward
NovartisNovartis owned a European patent (EP 0 948 320) relating to pharmaceutical compositions for sustained release of the HMG-CoA reductase inhibitor Fluvastatin. [read post]
10 Jul 2023, 5:58 am by Phil Dixon
Xylazine is a non-opioid sedative or tranquilizer that was first developed in 1962 by the pharmaceutical company Bayer. [read post]
27 Jun 2023, 10:00 am
Bayer Healthcare Pharmaceuticals, 24 F.4th 32 (1st Cir. 2022) to determine the government’s False Claims Act (FCA) dismissal authority. [read post]
Bayer’s Pharmaceuticals CEO Stefan Oelrich stated that he hopes this is “a first draft,” and that sharing data in such a time frame could have ” a catastrophic impact for Europe. [read post]
6 Mar 2023, 6:24 am by Kluwer Patent blogger
The members of this so-called Industry Patent Quality Charter (IPQC, including ATOS, Bayer, Deutsche Telekom, Drägerwerk AG & Co. [read post]
11 Feb 2023, 3:54 am by Kluwer Patent blogger
Members of the Industry Patent Quality Charter are companies such as Procter & Gamble, Ericcson, Syngenta, Siemens, HP, Volvo, Roche, Qualcomm, Vodafone, ATOs, Bayer and Deutsche Telekom. [read post]
6 Jan 2023, 2:33 pm by anne
In March, this pharmaceutical giant agreed to pay $260 million to resolve allegations that the company failed to pay amounts it owed under the Medicaid Drug Rebate Program. [read post]
24 Oct 2022, 12:00 am by Rose Hughes
In these cases, pharmaceutical drug doses and salt forms that were multiple steps removed from the prior art were found obvious in view of the normal step-by-step process and incentives of drug development. [read post]